DRACP04950 |
|
NFGYDLYRVRSSTSPTTN |
18 |
Synthetic |
DRACP04951 |
Chemokinostatin-1 |
NGREACLDPEAPMVQKIVQKMLKG |
24 |
CXCL1 |
DRACP04952 |
PF4 derived |
NGRKISLDLRAPLYKKIIKKLLES |
24 |
PF4 |
DRACP04953 |
Flt2-11 |
NITVTLKKFPL |
11 |
Synthetic |
DRACP04954 |
5a |
NOTAVAILABLE |
12 |
Synthetic |
DRACP04955 |
SvOrth-2 |
NVLLSPLSVATALSALSLGAEQRTES |
26 |
PEDF |
DRACP04956 |
|
PGLKGKRGDSGSPATWTTRG |
20 |
Synthetic |
DRACP04957 |
|
PIDERLRTCERLSYP |
15 |
Synthetic |
DRACP04958 |
|
PTGERLRTCERLSYP |
15 |
Synthetic |
DRACP04959 |
Kunitz-type serine protease inhibitor PIVL |
QDRPKFCYLPADPAECNAYMPRFYYDSASNKCKEFIYGGCRGNANNFKNRAECRHTCVAS |
60 |
Macrovipera lebetina |
DRACP04960 |
|
QEPHRHSIFTPQTNPRADLEKN |
22 |
Synthetic |
DRACP04961 |
|
QMIVIELGTNPLK |
13 |
Synthetic |
DRACP04962 |
|
QMIVIELGTNPLKSSGIENGAFQGMK |
26 |
Synthetic |
DRACP04963 |
C-C motif chemokine 7 |
QPVGINTSTTCCYRFINKKIPKQRLESYRRTTSSHCPREAVIFKTKLDKEICADPTQKWV |
60 |
Homo sapiens |
DRACP04964 |
Fibulostatin-6.3 |
QPWGTCSESCGKGTQTRAR |
19 |
Homo sapiens (Fibulin-6) |
DRACP04965 |
Thrombostatin con-1 |
QPWSQCSATCGDGVRERRR |
19 |
Homo sapiens (TSRC-1) |
DRACP04966 |
|
QQMNQKDFLSLIVS |
14 |
Synthetic |
DRACP04967 |
|
QRTESIIHRALYYDLIS |
17 |
Synthetic |
DRACP04968 |
|
RAGSPSGGPFCALARQPLTGSPPNERAFFCSSRDV |
35 |
Synthetic |
DRACP04969 |
|
RCRLAERRQIAK |
12 |
Synthetic |
DRACP04970 |
|
RGFTKMPHVQIHTEASESL |
19 |
Synthetic |
DRACP04971 |
|
RIFGESVSLRVQDWEW |
16 |
Synthetic |
DRACP04972 |
Flt1-12 |
RPFVEMYSEIPE |
12 |
Synthetic |
DRACP04973 |
|
RQVFQVAYIIIKA |
13 |
Synthetic |
DRACP04974 |
|
RREKQRPCDKPRR |
13 |
Synthetic |
DRACP04975 |
|
RRPAAAGKRRREKQRPSDKPRR |
22 |
Synthetic |
DRACP04976 |
|
RRPKGRAMRREKQRPSDKPRR |
21 |
Synthetic |
DRACP04977 |
|
RRPKGRGKRRREKQRPTDCHLCGDAVPRR |
29 |
Synthetic |
DRACP04978 |
Pentastatin-3 |
SAPFIECHGRGTCNYYANS |
19 |
Homo sapiens (α5 CIV) |
DRACP04979 |
Fibulostatin-6.1 |
SAWRACSVTCGKGIQKRSR |
19 |
Homo sapiens (Fibulin-6) |